FAQ
The legal questions people keep asking about peptides.
Straight answers to the distinction between prescription demand, research-market noise, and what pharmacies can actually compound today.
Category 1 is the safer path for traditional compounding because the FDA has not flagged the ingredient the same way. Category 2 means the FDA has raised substantial concerns, so pharmacies usually stop compounding it.